Growth Metrics

Fortress Biotech (FBIO) Income from Non-Controlling Interests (2016 - 2025)

Fortress Biotech (FBIO) has 11 years of Income from Non-Controlling Interests data on record, last reported at $3.0 million in Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests rose 121.53% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $8.9 million, down 81.14%, while the annual FY2024 figure was $74.9 million, 19.95% down from the prior year.
  • Income from Non-Controlling Interests reached $3.0 million in Q3 2025 per FBIO's latest filing, up from -$27.1 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $224.2 million in Q4 2022 and bottomed at -$36.9 million in Q4 2021.
  • Average Income from Non-Controlling Interests over 5 years is $6.2 million, with a median of -$13.8 million recorded in 2024.
  • The widest YoY moves for Income from Non-Controlling Interests: up 706.82% in 2022, down 256.19% in 2022.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$36.9 million in 2021, then skyrocketed by 706.82% to $224.2 million in 2022, then plummeted by 91.21% to $19.7 million in 2023, then skyrocketed by 139.55% to $47.2 million in 2024, then plummeted by 93.69% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were $3.0 million in Q3 2025, -$27.1 million in Q2 2025, and -$14.1 million in Q1 2025.